Stay updated about latest news and where to meet us!
SEPTEMBER 7, 2021 15:30 CEST
28 AUGUST 2021, 13:45 - 14:15 CEST
Dr. Adam Ameur presents a first-time application of droplet multiple displacement amplification followed by long-read sequencing to examine the genomic architecture of a single human cell. Make sure to register for this year's ESHG annual meeting to catch this exceptional talk!
Ten things you should think of when designing a good gene editing strategyBenjamin Schmid, Research Scientist, Cellular Engineering and Disease Models, Bioneer
How to ensure your gene editing validation accounts for larger unintended rearrangementsPeter Mouritzen, VP Application & Market Development, Samplix
20 APRIL 2021, 15:00 - 16:30 CEST
Don't miss Samplix sposored talk:
Validation of Genome Editing through Indirect Sequence Capture and Long-Read Sequencing
Peter Mouritzen, Vice President Application and Market Development, Samplix
Parallel Session 2: Long reads, Thursday March 11, 17:00 CET
4 MARCH 2021
Don't miss Samplix sposored talk on day #1:
January 26th 14:00 GMT
With the following talk about our technology:
Xdrop Technology for targeted enrichment of genomic regions for long- and short-read sequencing, Thursday, Decemeber 17th, 2020 12:30–12:45 CET, Peter Mouritzen · Samplix
With the following video poster (#55) about our technology:
A pivotal contribution to CRISPR-editing validatio, by Cristina Gamba, Samplix
Discover Xdrop: Whole Genome Amplification (WGA) in droplets for single cells,Thursday, November 19th, 2020 1:00 PM to 3:35 PM CET, Peter Mouritzen · Samplix
With the following talks about our technology:
Tackling Disease Related Repeat- Expansion Analysis By Xdrop Indirect Sequence Capture,Thursday, November 5, 2020 1:00 PM to 1:30 PM, Marzia Rossato · University of Verona
Xdrop – Validation Of Correct CRISPR Gene Editing, Thursday, November 5, 2020 3:30 PM to 4:00 PM, Peter Mouritzen · Samplix
Samplix has today launched a new CRISPR validation service using its Xdrop platform. This proprietary technology from Samplix can enrich genomic regions longer than 100 kb from as little as 1 ng genomic DNA and with single-molecule resolution. To read more, please see the full press release here.
We have received an overwhelming number of very high quality applications, so we have decided to award 4 grants instead of 3. All applications have been carefully reviewed by a team of 5 Samplix scientists.
PART 1: Tackling Disease-Related Repeat-Expansion Analysis - Dr. Marzia Rossato, Researcher, Functional Genomic Lab, University of Verona, Italy
PART 2: Validation of CRISPR in a 100 kb Region Surrounding the Editing Site - Dr. Peter Mouritzen, Application Development Services, Samplix, Denmark
PART 3: The Launch of a Grant Program and Q&A
Bioneer provides customized gene editing services including advanced quality control of gene edited cell models and will through their partnership with Samplix offer their customers access to the Xdrop technology.
Learn more: Bioneer and CRISPR Editing Verification.
Today, Samplix launched its comprehensive service program to grant any laboratory access to the advantages of Xdrop technology. To read more, please see the full press release here:
We look forward to meeting you at 2020's European Society for Human Genetics (ESHG) Conference in Berlin.
During ESHG, we will be presenting our Xdrop instrument.
Samplix will be attending - and presenting - at the Genome Editing 2020 conference on March 12. Dr Peter Mouritzen, Vice President Application and Market Development at Samplix will be presenting the following talk:
Xdrop – A New Microfluidics Technology for the Analysis of CRISPR Editing
To see the conference agenda and register for the event, please visit the conference website.
Samplix is pleased to announce we will be demonstrating our recently launched Xdrop system at the 8th Plant and Gene Editing Congress: Europe, 4-5 March, 2020.
To see more and register for the event, please visit the conference website.
Samplix is pleased to announce we will be demonstrating our recently launched Xdrop system at the EMBL Heidelberg Cancer Genomics 2019 conference in Heidelberg.
To see more and register for the event, please visit the conference website:
Samplix is pleased to announce we will be demonstrating our recently launched Xdrop system at the Oxford Global 11th Annual NGS & Clinical Diagnostics Congress in London.
Samplix is pleased to announce we will be attending the Genomic Medicine 2019 Nordic conference 13 - 14 November at Kennedy Center at Rigshospitalet in Copenhagen.
Samplix is pleased to announce we will be attending the Genomic Medicine 2019 Cambridge conference 20 - 21 November at Murray Edwards College in Cambridge, UK
02 September 2019. Today, Samplix is happy to announce the commercial launch of our Xdrop instrument for the targeted enrichment of long genomic regions from as little as 1 ng of DNA.
Scientists in the genomics field can now routinely capture up to 100 kb long genomic regions, based upon very limited target sequence information (100-200 bp of sequence). Using Xdrop technology together with long- or short-read sequencers makes it possible to sequence into regions that were previously inaccessible.
The types of genomic regions that are now unlocked by the Xdrop technology include:
Today, Samplix announced the commercial launch of its Xdrop sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.
To read more, please see the full press release here:
January 2019. Samplix is pleased to announce that the company has been selected by the European Commission among the winners of the prestigious Horizon 2020 – SME Instrument program, obtaining €1.9 million to mature its proprietary Xdrop technology. The selection process was highly competitive with more than 1.800 applicants and a success rate of only about 3%.
Samplix’ proprietary Xdrop technology comprises novel microfluidics, chemistry and bioinformatics in a simple work process that allows scientists and clinicians to partition millions of single molecules in droplets, thereby enabling both targeted enrichment and high-quality amplification of single molecules for sequencing analysis.
The Xdrop technology is currently in beta test at leading research institutions world-wide.
“We are excited to receive recognition and support by the European Commission for completion of our product development towards commercial launch of the Xdrop solution later this year” said CEO Lars Kongsbak.
To read more about Horizon 2020 SME awards, please visit European Commission website:
ContactBregnerødvej 963460 BirkerødDenmark
firstname.lastname@example.orgPhone: (+45) 82 30 45 00
CVR 32 30 93 21
Connect with us
Copyright © 2021 Samplix® ApS. All rights reserved. For Research Use Only. Not for use in diagnostic procedures.Webdesign: www.reklamehuset.dk